135
Participants
Start Date
December 31, 1995
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
fluorescence in situ hybridization
loss of heterozygosity analysis
polymerase chain reaction
flow cytometry
immunohistochemistry staining method
Fredericksburg Oncology, Incorporated, Fredericksburg
Mayo Clinic - Jacksonville, Jacksonville
Wood County Oncology Center, Bowling Green
Flower Hospital Cancer Center, Sylvania
Fulton County Health Center, Wauseon
Toledo Hospital, Toledo
St. Vincent Mercy Medical Center, Toledo
Medical University of Ohio Cancer Center, Toledo
St. Charles Mercy Hospital, Oregon
Toledo Clinic - Oregon, Oregon
CCOP - Toledo Community Hospital, Toledo
St. Anne Mercy Hospital, Toledo
Toledo Clinic, Incorporated - Main Clinic, Toledo
Community Cancer Center, Elyria
Hematology Oncology Center, Elyria
Mercy Hospital of Tiffin, Tiffin
Lima Memorial Hospital, Lima
Community Cancer Center of Monroe, Monroe
Mercy Memorial Hospital - Monroe, Monroe
Hickman Cancer Center at Bixby Medical Center, Adrian
CCOP - Iowa Oncology Research Association, Des Moines
John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines
Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines
Medical Oncology and Hematology Associates at Mercy Cancer Center, Des Moines
Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines
John Stoddard Cancer Center at Iowa Lutheran Hospital, Des Moines
Medical Oncology and Hematology Associates - West Des Moines, Clive
CCOP - Duluth, Duluth
Miller - Dwan Medical Center, Duluth
Mayo Clinic Cancer Center, Rochester
MeritCare Bemidji, Bemidji
Rapid City Regional Hospital, Rapid City
MeritCare Broadway, Fargo
CCOP - MeritCare Hospital, Fargo
St. Alexius Medical Center Cancer Center, Bismarck
Mayo Clinic Scottsdale, Scottsdale
Essentia Health - Duluth Clinic, Duluth
Northwest Ohio Oncology Center, Maumee
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER